Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Control Trial to Compare the Efficacy of the Revi System Therapy on Versus Off in Relieving Urinary Urge Incontinence Episodes.

NCT06217328 is registered in ClinicalTrials.gov with BlueWind Medical as lead sponsor.

NCT NCT06217328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06217328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Control Trial to Compare the Efficacy of the Revi System Therapy on Versus Off in Relieving Urinary Urge Incontinence Episodes.
Lead sponsor
BlueWind Medical
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 24, 2024
Completion date
February 28, 2027
Enrollment
117 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

urinary urge incontinence